Systematic review and meta-analysis: susceptibility-guided versus empirical antibiotic treatment forHelicobacter pyloriinfection
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systematic review and meta-analysis: susceptibility-guided versus empirical antibiotic treatment forHelicobacter pyloriinfection
Authors
Keywords
-
Journal
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume 70, Issue 9, Pages 2447-2455
Publisher
Oxford University Press (OUP)
Online
2015-06-16
DOI
10.1093/jac/dkv155
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pretreatment Antimicrobial Susceptibility-Guided Vs. Clarithromycin-Based Triple Therapy for Helicobacter pylori Eradication in a Region With High Rates of Multiple Drug Resistance
- (2014) Chung-Su Park et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Efficacy of TailoredHelicobacter pyloriEradication Treatment Based on Clarithromycin Susceptibility and Maintenance of Acid Secretion
- (2014) Mitsushige Sugimoto et al. HELICOBACTER
- Eradication of Helicobacter pylori According to 23S Ribosomal RNA Point Mutations Associated With Clarithromycin Resistance
- (2013) H. J. Lee et al. JOURNAL OF INFECTIOUS DISEASES
- Helicobacter pylorieradication in Western Australia using novel quadruple therapy combinations
- (2012) C. Y. Tay et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Culture-based Selection Therapy for Patients Who Did Not Respond to Previous Treatment for Helicobacter pylori Infection
- (2012) Giulia Fiorini et al. Clinical Gastroenterology and Hepatology
- Usefulness of antimicrobial susceptibility in the eradication of Helicobacter pylori
- (2012) A. Cosme et al. CLINICAL MICROBIOLOGY AND INFECTION
- Management ofHelicobacter pyloriinfection—the Maastricht IV/ Florence Consensus Report
- (2012) Peter Malfertheiner et al. GUT
- Helicobacter pyloriresistance to antibiotics in Europe and its relationship to antibiotic consumption
- (2012) Francis Megraud et al. GUT
- Eradication of Helicobacter pylori in Children in Vietnam in Relation to Antibiotic Resistance
- (2012) Thi Viet Ha Nguyen et al. HELICOBACTER
- Nonbismuth Quadruple (Concomitant) Therapy: Empirical and Tailored Efficacy versus Standard Triple Therapy for Clarithromycin-Susceptible Helicobacter pylori and versus Sequential Therapy for Clarithromycin-Resistant Strains
- (2012) Javier Molina-Infante et al. HELICOBACTER
- Sitafloxacin resistance in Helicobacter pylori isolates and sitafloxacin-based triple therapy as a third-line regimen in Japan
- (2012) Yoshihiro Hirata et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: a multicentre clinical trial
- (2012) J.-M. Liou et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Dual therapy for third-lineHelicobacter pylorieradication and urea breath test prediction
- (2012) Toshihiro Nishizawa WORLD JOURNAL OF GASTROENTEROLOGY
- Helicobacter pylori treatment in the era of increasing antibiotic resistance
- (2010) D. Y. Graham et al. GUT
- Is Antimicrobial Susceptibility Testing Necessary Before First-line Treatment for Helicobacter pylori Infection? -Meta-analysis of Randomized Controlled Trials-
- (2010) Yuan Wenzhen et al. INTERNAL MEDICINE
- Helicobacter pyloriInfection
- (2010) Kenneth E.L. McColl NEW ENGLAND JOURNAL OF MEDICINE
- The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
- (2009) Alessandro Liberati et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Tailored eradication therapy based on fecalHelicobacter pyloriclarithromycin sensitivities
- (2008) Takashi Kawai et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Gatifloxacin-based triple therapy as a third-line regimen forHelicobacter pylorieradication
- (2008) Toshihiro Nishizawa et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started